Evaluation of the quality of blood components prepared using the Reveos automated blood processing system

Vox Sanguinis

Volumn 105, Issue 3, 2013, Pages 225-235

  Johnson, L ^a   Winter, K M ^a   Kwok, M ^a   Reid, S ^a   Marks, D C ^a  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

Author keywords

Automation; Blood components; Blood processing; Interim platelet unit

Indexed keywords

CYTOKINE; GLUCOSE; LACTIC ACID; PADGEM PROTEIN; PHOSPHATIDYLSERINE; THROMBOCYTE CONCENTRATE;

ARTICLE; BLOOD COMPONENT; ERYTHROCYTE; GLUCOSE METABOLISM; HUMAN; IN VITRO STUDY; LABORATORY AUTOMATION; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUALITY CONTROL; REDUCTION; SHOCK; THAWING; THROMBOCYTE; THROMBOCYTE ACTIVATION;

AUTOMATION; BLOOD COMPONENTS; BLOOD PROCESSING; INTERIM PLATELET UNIT;

AUSTRALIA; BLOOD CELL COUNT; BLOOD COMPONENT REMOVAL; BLOOD COMPONENT TRANSFUSION; BLOOD PLATELETS; ERYTHROCYTES; HUMANS; LEUKOCYTES; PLASMA; REFERENCE STANDARDS; TIME FACTORS;

EID: 84884291652     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12051     Document Type: Article

References (33)

1. Vetlesen A, Mirlashari MR, Ezligini F, et al.: Evaluation of platelet activation and cytokine release during storage of platelet concentrates processed from buffy coats either manually or by the automated OrbiSac system. Transfusion 2007; 47:126-132.
2. Janetzko K, Klüter H, Waeg GV, et al.: Fully automated processing of buffy-coat-derived pooled platelet concentrates. Transfusion 2004; 44:1052-1058.
3. Isola H, Kientz D, Wiesel M, et al.: The use of TACSI system: effect of automation on routine production of pooled platelet concentrates for pathogen inactivation in a french regional blood centre. Vox Sang 2010; 99:(Suppl. 1)91-516.
4. Lagerberg JW, Salado-Jimena JA, Löf H, et al.:Evaluation of the quality of blood components obtained after automated separation of whole blood by a new multiunit processor. Transfusion 2013; 53:1798-1807.
5. Johnson L, Reid S, Tan S, et al.: PAS-G supports platelet reconstitution after cryopreservation in the absence of plasma. Transfusion 2013; doi: 10.1111/trf.12084. [Epub ahead of print].
6. Johnson L, Winter KM, Hartkopf-Theis T, et al.: Evaluation of the automated collection and extended storage of apheresis platelets in additive solution. Transfusion 2012; 52:503-509.
7. Johnson L, Winter KM, Reid S, et al.: The effect of pathogen reduction technology (Mirasol) on platelet quality when treated in additive solution with low plasma carryover. Vox Sang 2011; 101:208-214.
8. Johnson LN, Winter KM, Reid S, et al.: Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution. Cryobiology 2011; 62:100-106.
9. Australian Red Cross Blood Service: Blood Component Information: Circular of Information. Melbourne, Australian Red Cross Blood Service, 2012
10. Council of Europe: Guide to the preparation, use and quality assurance of blood components. Strasbourg, Council of Europe Press, 2008
11. Jurado M, Algora M, Garcia-Sanchez F, et al.: Automated processing of whole blood units: operational value and in vitro quality of final blood components. Blood Transfusion 2012; 10:63-71.
12. Sandgren P, van Waeg G, Verheggen C, et al.: Storage of interim platelet units for 18 to 24 hours before pooling: in vitro study. Transfusion 2011; 51:1213-1219.
13. Maia S, Duarte S, Pacheco R, et al.: Optimization of platelet pool content using the Atreus system and the platelet yield indicator. Transfusion 2009; 49:99A.
14. Zhang JG, Carter CJ, Culibrk B, et al.: Buffy-coat platelet variables and metabolism during storage in additive solutions or plasma. Transfusion 2008; 48:847-856.
15. Dijkstra-Tiekstra MJ, Kuipers W, Setroikromo AC, et al.: Platelet capacity of various platelet pooling systems for buffy coat-derived platelet concentrates. Transfusion 2008; 48:2114-2121.
16. Holme S, Sweeney JD, Sawyer S, et al.: The expression of P-selectin during collection, processing, and storage of platelet concentrates: relationship to loss of in vivo viability. Transfusion 1997; 37:12-17.
17. Krailadsiri P, Seghatchian J: Effect of processing and storage on platelet activation, cellular injury and microvesiculation. Transfus Apheres Sci 2001; 24:237-238.
18. Johnson LN, Winter KM, Reid S, et al.: In Vitro Quality of Platelet Concentrates Produced with the TACSI from 4 Buffy Coats and Subsequent Storage in Platelet Additive Solution. Transfusion 2011; 51(Suppl):59A.
19. Sandgren P, Hild M, Sjödin A, et al.: Storage of Buffy-coat-derived platelets in additive solutions: in vitro effects on platelets prepared by the novel TACSI system and stored in plastic containers with different gas permeability. Vox Sang 2010; 99:341-347.
20. Keuren JFW, Cauwenberghs S, Heeremans J, et al.: Platelet ADP response deteriorates in synthetic storage media. Transfusion 2006; 46:204-212.
21. Thiele T, Iuga C, Janetzky S, et al.: Early storage lesions in apheresis platelets are induced by the activation of the integrin αIIbβ3 and focal adhesion signaling pathways. J Proteomics 2012; 76:297-315.
22. Panzer S, Jilma P: Methods for testing platelet function for transfusion medicine. Vox Sang 2011; 101:1-9.
23. van der Meer PF, Kerkhoffs J-L, Curvers J, et al.: In vitro comparison of platelet storage in plasma and in four platelet additive solutions, and the effect of pathogen reduction: a proposal for an in vitro rating system. Vox Sang 2010; 98:517-524.
24. Ostrowski SR, Bochsen L, Salado-Jimena JA, et al.: In vitro cell quality of buffy coat platelets in additive solution treated with pathogen reduction technology. Transfusion 2010; 50:2210-2219.
25. Seghatchian J: Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers. Transfus Apheres Sci 2006; 34:125-130.
26. Ezuki S, Kanno T, Ohto H, et al.: Survival and recovery of apheresis platelets stored in a polyolefin container with high oxygen permeability. Vox Sang 2008; 94:292-298.
27. Van Der Meer P, Pietersz R, Reesink H: Leucoreduced platelet concentrates in additive solution: an evaluation of filters and storage containers. Vox Sang 2001; 81:102-107.
28. Salado-Jimena J, Nielsen C, van Waeg G, et al.: Validation of red cells and plasma obtained with a new integrated blood separation device. Vox Sang 2011; 101:167.
29. Thomas S, Hancock V, Cardigan R: Repeated short-term warming of red blood cell concentrates has minimal effect on their quality. Vox Sang 2012; 103:113-121.
30. Heaton A, Keegan T, Holme S: In vivo regeneration of red cell 2, 3-diphosphoglycerate following transfusion of DPG-depleted AS-1, AS-3 and CPDA-1 red cells. Br J Haematol 1989; 71:131-136.
31. Hess JR: An update on solutions for red cell storage. Vox Sang 2006; 91:13-19.
32. Sousa NC, Anicchino-Bizzacchi JM, Locatelli MF, et al.: The relationship between ABO groups and subgroups, factor VIII and von Willebrand factor. Haematologica 2007; 92:236-239.
33. Cardigan R, Van der Meer PF, Pergande C, et al.: Coagulation factor content of plasma produced from whole blood stored for 24 hours at ambient temperature: results from an international multicenter BEST Collaborative study. Transfusion 2011; 51:50S-57S.